BioHealth News Archive
Implementing GMP For Early-Phase Development With Cartesian Therapeutics Co-Founder And CEO Dr Murat Kalayoglu
A key factor in the success of a developing drug or therapy is the success of early clinical trials. A focus on Good Manufacturing…
Read MoreJohns Hopkins Tech Ventures startups saw $1B in investment in fiscal 2021 – Baltimore Business Journal
Startups with ties to Johns Hopkins ties have contributed significantly to the highest-ever amounts of capital being raked in across Maryland and beyond. For…
Read MoreJohns Hopkins Technology Ventures – Fiscal Year 2021 Annual Report
I'm pleased to share with you JHTV's annual report for Fiscal Year 2021. The pandemic made FY21 an unusual one, but the JHTV team…
Read MoreBXP Life Sciences Expands with Montgomery County, Maryland Acquisition – BioHealth Capital Region
BOSTON – July 27, 2021 – Boston Properties, Inc. (NYSE: BXP), the largest publicly traded developer, owner, and manager of Class A office properties in…
Read More50 Over 50 2021: Vision
Armed with brilliant ideas, experience and a determination to disrupt, these 50 women are making an impact on society and culture through healthcare, robotics,…
Read MoreSonosa Medical Spins Out of the MDC Studio
The MDC Studio is pleased to announce the spin-out of the company, Sonosa Medical, Inc., as an independent entity. Founded in 2019, Sonosa Medical…
Read MoreJoin United Therapeutics Corporation…..
This is what it is ALL about - the largest 3D printed hydrogel. This lung model can be perfused and ventilated and this blueprint…
Read MoreNCI Technology Transfer Center (TTC) Communications for Industry Partners
Public reporting burden for this collection of information is estimated to average 10 minutes per response, including the time for reviewing instructions, searching existing…
Read MoreFZata Announces First-in-Class “Live Biologics In A Pill” Platform Entering Manufacturing Phase · BioBuzz
FZata, Inc. is developing our ground-breaking “Live Biologics In A Pill” platform for oral delivery of live biologics. Live Biologics In A Pill will…
Read MoreHow these 50 innovators on our DC Inno on Fire list are heating up the startup universe – Washington Business Journal
We’re taking a closer look at each of the 50 winners of our 2021 Inno on Fire honorees. {iframe}https://www.bizjournals.com/washington/news/2021/08/13/50-inno-on-fire-awards-closer-look-2021.html?ana=e_wash_bn_exclusive_exclusive&j=90567805&t=Breaking%20News&mkt_tok=NjczLVVXWS0yMjkAAAF-314prdtJe57vr-MSfP9bXpcH-4SwqQ8fvYZ_ctcCGZQuE9CF_8xZhWQFqsGTgfF3MuynnTl6xPJqiiJdxjTf7uBo2g6pIQ_s_cAWeeIwd6sn9pFn{/iframe}
Read MoreFDA new drug applications to cost more than $3M in 2022
Starting in 2022, drugmakers filing new drug applications with clinical data will have to pay the FDA $3.1 million. The FDA's fee for new…
Read MoreHow A Disconnected Biohealth Ecosystem Became The Next Big Thing – YouTube
Jeff Galvin, CEO of American Gene Technologies and Rich Bendis, CEO and President of BioHealth Innovation, Inc. have a fireside chat about the rapid…
Read MoreDr. Anne Khademian ,Executive Director, The Universities at Shady Grove, Welcomes Rich Bendis to #ThisIsUSG Podcast”
In this episode of #ThisIsUSG, BioHealth Innovation President and CEO Rich Bendis joins Dr. Anne Khademian for a discussion about BioHealth Innovation's role in…
Read MoreBHI EIR Feedback Day August 18th. Register Now!
Are you a biohealth start-up in Maryland, DC or Virginia seeking feedback on your biohealth business idea, pitch deck, or commercialization plan? Schedule your…
Read MoreMedcura raises $7.4 Million to Expand FDA-Approved Line of Hemostatic and Wound Treatment Products
RIVERDALE, Md., Aug. 12, 2021 /PRNewswire/ -- Medcura, Inc., a commercial-stage medical device company, today announced it has raised $7.4 million in private equity to…
Read More